Technical Analysis for CRGX - CARGO Therapeutics, Inc.

Grade Last Price % Change Price Change
F 17.20 3.61% 0.60
CRGX closed up 3.61 percent on Thursday, July 11, 2024, on 1.57 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Weak + Overbought Other 0.00%
Weak, Overbought and Reversal Signs Reversal 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%

   Recent Intraday Alerts

Alert Time
Up 5% about 15 hours ago
Upper Bollinger Band Resistance about 15 hours ago
Possible NR7 about 15 hours ago
Rose Above Previous Day's High about 19 hours ago
Rose Above Upper Bollinger Band about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immune System Tumor Cancer Immunotherapy Gene Therapy Therapies For Cancer T Cells Antigen Cd22 Car T Cell Siglec

Is CRGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 33.92
52 Week Low 13.14
Average Volume 188,391
200-Day Moving Average 0.00
50-Day Moving Average 18.08
20-Day Moving Average 15.91
10-Day Moving Average 16.08
Average True Range 1.02
RSI (14) 54.13
ADX 13.81
+DI 28.88
-DI 20.39
Chandelier Exit (Long, 3 ATRs) 15.26
Chandelier Exit (Short, 3 ATRs) 17.57
Upper Bollinger Bands 17.45
Lower Bollinger Band 14.37
Percent B (%b) 0.92
BandWidth 19.37
MACD Line -0.46
MACD Signal Line -0.77
MACD Histogram 0.3113
Fundamentals Value
Market Cap 708.73 Million
Num Shares 41.2 Million
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.03
Resistance 3 (R3) 18.06 17.81 17.89
Resistance 2 (R2) 17.81 17.60 17.80 17.84
Resistance 1 (R1) 17.51 17.47 17.66 17.48 17.80
Pivot Point 17.26 17.26 17.34 17.25 17.26
Support 1 (S1) 16.96 17.05 17.11 16.93 16.60
Support 2 (S2) 16.71 16.92 16.70 16.56
Support 3 (S3) 16.41 16.71 16.51
Support 4 (S4) 16.38